Company & Sponsor Intelligence

University of Cambridge

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting1

Completed1

Countries2

Therapeutic footprint

alzheimersautismdepressionstroke

Indexed studies

NCT02804867Spot Depression Study
depression · United KingdomCOMPLETED

NCT04330222Cambridge 7 Tesla Cerebral Small Vessel Disease Study
stroke · United KingdomUNKNOWN

NCT07786116The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
alzheimers · United KingdomNA

NCT02065193Prevalence of Autism Spectrum Conditions in Mainland China
autism · ChinaUNKNOWN

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →